Michael Kelly, MD, PhD
Professor of Pediatrics
Northeast Ohio Medical University
Lymphangiomatosis & Gorham Stout Disease Alliance (LGDA)
Dr. Michael Kelly became LGDA’s Executive Director in 2021. He brings years of experience as a director of clinical and research programs focused on pediatric and young adult patients with rare diseases, including complex lymphatic anomalies (CLA).
Dr. Kelly works closely with the staff and the LGDA board to ensure the organization continues to meet the changing needs of the CLA patient community focusing on important issues that improve quality of life and ultimately cures.
Dr. Kelly joined LGDA in June of 2020 as the Chief Medical Officer to strengthen national and international collaborations that promoted our understanding of CLAs with the goal of providing more effective and safer therapies for children and adults.
Dr. Kelly attended the University of Cincinnati in 1980-1985, staying on to finish his MD, PhD in 1993. Dr. Kelly then completed his Pediatric residency and Hematology/Oncology fellowship at Washington University in St. Louis in 1998. He was the Pediatric Cancer Program Director at the Medical College of Wisconsin, Children’s Hospital of Wisconsin and most recently the Chief Research Officer at Akron Children’s Hospital.